There is a solution
to the opioid crisis.
The story must be told.

Ibogaine is a naturally occurring psychoactive substance, derived from the root bark of a shrub found in
the Congo basin. Ibogaine may also be semi-synthesized from a variety of other plants, and potentially
fully synthesized in the laboratory. Ibogaine is not yet recognized as a registered drug but is on the
Prescription Drug List in Canada. Ibogaine is being utilized at addiction treatment centers in countries
such as New Zealand, Mexico, Brazil, South Africa, and legally in the Bahamas and Mauritius.

Get the latest news on everything ibogaine

View Videos

Videos

Universal Ibogaine is preparing to go public

LEARN MORE

The process behind addiction-interruption treatment with ibogaine with Shayne Nyquvest

LEARN MORE

Creating the gold standard for addiction treatment - Dr. Alberto Sola

LEARN MORE

How opioid addiction can be a thing of the past - Travis Hayes

LEARN MORE

How a plant may be the solution to the opioid epidemic - Ian Campbell

LEARN MORE

Why education is crucial to curb the opioid epidemic Colleen Clandening

LEARN MORE
VIEW MORE

Why education is crucial to curb the opioid epidemic Colleen Clandening

LEARN MORE

Andrew O'Donnel Supercharged Stocks on Ibogaine

LEARN MORE

The Case for Ibogaine | Thomas Kingsley Brown | TEDxVeniceBeach

LEARN MORE

Ibogaine: Cure For A Crisis

LEARN MORE

We provide safe, effective and affordable ibogaine treatment globally

LEARN MORE

"Behind the Buzz" Show: Universal Ibogaine Inc. Chairman & Director Shayne Nyquvest

LEARN MORE

Opioid epidemic: the medical industry created a public health crisis | Chris Johnson, MD | TEDxEdina

LEARN MORE

Documentary

This documentary seeks to inform the public about how ibogaine can be used to help fight the opioid crisis that is plaguing North America.In simple terms, ibogaine is an extremely fast-acting, plant based, naturally-occurring substance, which alleviates withdrawal symptoms and interrupts the process of active addiction. Ibogaine provides a gentle, painless, and very rapid detox from opioids such a heroin, methadone, OxyContin, Suboxone & Subutex; stimulants like cocaine, crack and methamphetamine, as well as alcohol and many other addictive drugs

Request Access to Investment Alerts!

Blog

Ann Arbor City Council votes to decriminalize psychedelic mushrooms with unanimous vote

ANN ARBOR, Mich. (FOX 2) - Psychedelic mushrooms are illegal under state and federal law but there is a push to legalize them in Ann Arbor. And the idea of creating a city ordinance that would decriminalizing psychedelic mushrooms and other plant-based hallucinogenics came about in a very organic way.

Learn More

The NFL Painkiller Problem

Football is one of the toughest contact sports, and this contact has resulted in countless injuries for NFL players.While over the counter pain medications like ibuprofen or amoxicillin may have helped players in the past, increasingly potent opioids are the new mainstay for treating pain related to football injuries and surgeries. The prevalence of painkillers has led to opioid addiction among players and former players.

Learn More

U.S. states seek $2.2 trillion from OxyContin maker Purdue Pharma: filings

U.S. states claimed they are owed $2.2 trillion to address harm from OxyContin maker Purdue Pharma LP’s alleged role in America’s opioid epidemic, accusing the drugmaker in new filings of pushing prescription painkillers on doctors and patients while playing down the risks of abuse and overdose.

Learn More

Ibogaine and the Reinvention of Addiction Recovery w. Shayne Nyquvest and Jeremy Weate

The opioid crisis has created a pressing need for successful addiction treatments, especially as the majority of people who seek treatment are highly likely to relapse.In today’s episode, we speak with Founder and Co-Chairman, Shayne Nyquvest and CEO, Jeremy Weate at Universal Ibogaine.

Learn More

2020 Psychedelics Industry Insights Report

2020 Psychedelics Industry Insights Report‍ Nikita Alexandrov BChem, MBA-CTO,ThinkMyco Jan 11th, 2020 2019 was a pivotal year in the psychedelic industry with US decriminalization actions, two companies receiving FDA breakthrough status for psilocybin, funding of the $16M Johns Hopkins Psychedelic Research Center,The US Defence Department starting their rumored $20M+ Focused Pharma psychedelic science program and ...

Learn More

Cannacord Psychedelic Derived Medicines and Therapies Industry Report

Psychedelic Derived Medicines and Therapies Mental health miracle or another bad trip? When most of us think of psychedelic drugs, we think of the 1960s counterculture. We think of anti-establishment, anti-war, anti-capitalist hippies, Woodstock, tie-dye, Lucy in the Sky, peace, love and bell bottom jeans. But before psychedelics became ingrained in the counterculture, they were found in a lab.

Learn More
VIEW MORE

Justice Department Seeks as Much as $18.1 Billion From Purdue Pharma

Addiction experts are in wide agreement on the most effective way to help opioid addicts: Medication-assisted treatment. But most inpatient rehab facilities in the U.S. don’t offer this option. WSJ’s Jason Bellini reports on why the medication option is controversial, and in many places, hard to come by. Image: Ryno Eksteen and Thomas Williams

Learn More

Opioid Crisis: The lawsuits that could bankrupt manufacturers and distributors

A judge in Oklahoma has ruled that Johnson & Johnson helped fuel the state's opioid crisis and has ordered the company to pay $572 million for its role. Recently, "60 Minutes" reported on Mike Moore, an attorney representing state and local governments that, like Oklahoma, are taking drug makers to court.

Learn More

Fayth’s Story: Love, addictions and determination on Vancouver’s Downtown Eastside

Fayth Rose Alexis was born March 8, 1982 in Bella Coola, British Columbia. Her mother Mavis Benson was just 16 at the time. “Being really ...

Learn More

The Multibillion-Dollar Opioid Crisis Has a Plant Medicine Solution

Investors and markets alike are getting excited about medicinal psychedelics, but this isn’t the first appearance for the plant-based medicinal wave. On the contrary, researchers at universities and government labs have been studying the positive therapeutic effects of psychedelics for years.

Learn More

Investing Opportunity in Psychedelics: 95% Effective Opioid Withdrawal Treatment

It can be tough to understand the severity of the opioid epidemic sweeping the world. But the reality is that the crisis is growing in Canada and around the world. Millions of people have been affected and continue to suffer, and the economic drain has ballooned to trillions of dollars in the US alone.

Learn More

Vancouver drug researcher talks psychedelics on Gwyneth Paltrow's Goop Lab

Mark Haden, the executive director of MAPS Canada, discusses the therapeutic use of psychedelics with Paltrow and her staff.

Learn More

Business gets ready to trip: How psychedelic drugs may revolutionize mental health care

Silicon Valley legends. Billionaire financiers. Patent attorneys. They're all awakening to the massive potential of an industry preparing to emerge from darkness.

Learn More

The emerging psychedelics industry is giving new hope to addiction medicine

Universal Ibogaine Inc. has a plan to curb the number of ... and many, including the National Institute on Drug Abuse, have pointed to the ...

Learn More

Here’s what you need to know about the ongoing opioid overdose crisis during COVID-19

According to a statement from the British Columbia Centre on Substance Use, the declaration made on March 17 of a public health emergency related to COVID-19 in British Columbia means that the province is facing two concurrent crises: one, the rapid spread of the novel coronavirus and another, the ongoing opioid overdose crisis.

Learn More

Gwyneth Paltrow Goop with Our Dr. Deborah Mash

“Ibogaine made them ready for change,” says researcher Deborah Mash, PhD. Mash has been studying the effects of ibogaine since 1992.

Learn More

Request Access to Investment Alerts!